LBT Innovations Secures AstraZeneca Deal: AI in Pharma Manufacturing
Brent Barnes, CEO of LBT Innovations, shares insights into the company’s groundbreaking AI technology, APAS Independence, and its recent contract with AstraZeneca. Discover how LBT is addressing critical data integrity issues in the pharmaceutical industry and their plans for growth in a $2.8 billion market.
Subscribe to our channel now for more videos like this one: http://bit.ly/WIonYouTube
Find out more about how Wholesale Investor helps businesses successfully raise capital:
https://hello.wholesaleinvestor.com/w...
About Wholesale Investor:
Wholesale Investor is a leading AI-Driven Private Capital Marketplace that connects Private Market Opportunities (Venture, Private Equity, Funds, Property, Credit and Digital Assets) that are looking to raise capital with an active and growing ecosystem of over 45,000+ high-net-worth investors, fund managers, family offices, Directors, PE and VC firms, and government.
Connect with Wholesale Investor Online:
►Twitter: / wholesaleinvest
►Facebook: / wholesaleinvest
►Linkedin: / wholesale-investor
►Website: https://wholesaleinvestor.com.au/
Watch video LBT Innovations Secures AstraZeneca Deal: AI in Pharma Manufacturing online without registration, duration hours minute second in high quality. This video was added by user Wholesale Investor 21 August 2024, don't forget to share it with your friends and acquaintances, it has been viewed on our site 12 once and liked it lik people.